In response to our concerns, the applicant commented that it is committed to providing the clinical evidence necessary to satisfy the substantial clinical improvement standard and indicated that it is currently conducting an ongoing prospective, multicenter, open-label, single-arm clinical study [44] to evaluate the Axoguard HA+ Nerve Protector TM in patients undergoing a first revision cubital tunnel decompression procedure for recurrent or recalcitrant cubital tunnel syndrome
An inflamed gut feels loud, with cramps, bloating, urgency, or off days that never end
Our expert team takes a personalized approach to care, tailoring treatments to meet your unique needs and goals
NAD+ IV therapy involves the intravenous administration of nicotinamide adenine dinucleotide (NAD+), a coenzyme found in all living cells
What you need: 1
A clinical trial registration (NCT02637284) appears on ClinicalTrials.gov with a status listed as unknown since 2016